Definitive Healthcare’s Q2 2026 earnings reveal a mixed but promising picture: revenue dipped 9% year-over-year to $55.2M, yet adjusted EBITDA soared past guidance at $14.6M, fueled by strong cash flow of $50M over the last 12 months. While life sciences lags, provider and diversified segments show clear growth momentum—making up over 60% of revenue. Net dollar retention is rising for the second straight quarter, and key life sciences wins—including reacquired clients—are validating their data quality and service-driven strategy. Ahead, they’re accelerating on four strategic pillars: AI-enhanced data, faster integrations, customer success, and innovation—with “Turbo,” their new AI-powered platform, set to launch soon. Though it won’t move the needle on 2026 revenue, Turbo aims to boost retention through tiered, usage-based pricing and deeper customer engagement.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
